N -Methyl-D-Aspartate (NMDA) receptor modulators: a patent review (2015-present)
- 14 September 2020
- journal article
- other
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 30 (10) , 743-767
Abstract
– The NMDA receptor is implicated in various diseases including neurodegenerative, neurodevelopmental and mood disorders. However, only a limited number of clinically approved NMDA receptor modulat...Keywords
This publication has 184 references indexed in Scilit:
- Influence of GluN2 subunit identity on NMDA receptor functionNeuropharmacology, 2013
- The Subtype of GluN2 C-terminal Domain Determines the Response to Excitotoxic InsultsNeuron, 2012
- Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memoryNeurobiology of Learning and Memory, 2011
- Structure and mechanism of glutamate receptor ion channel assembly, activation and modulationCurrent Opinion in Neurobiology, 2011
- Family‐based genetic association study of DLGAP3 in Tourette SyndromeAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2010
- High dose D-serine in the treatment of schizophreniaSchizophrenia Research, 2010
- Quinazolin-4-one Derivatives: A Novel Class of Noncompetitive NR2C/D Subunit-SelectiveN-Methyl-d-aspartate Receptor AntagonistsJournal of Medicinal Chemistry, 2010
- Influence of the NR3A subunit on NMDA receptor functionsProgress in Neurobiology, 2010
- In developing hippocampal neurons, NR2B-containing N-methyl-d-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal deathNeuroscience, 2009
- Effects of a NR2B selective NMDA glutamate antagonist, CP‐101,606, on dyskinesia and parkinsonismMovement Disorders, 2008